Meilin Liu
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Blood Pressure and Hypertension Studies 3
- Lipid metabolism and disorders 3
- Cardiac Fibrosis and Remodeling 3
- Atrial Fibrillation Management and Outcomes 2
-
- Atherosclerosis and Cardiovascular Diseases 3
-
- Lipoproteins and Cardiovascular Health 5
-
- Cancer, Lipids, and Metabolism 5
- Journals
- Circulation (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meilin Liu
37 papers receiving 467 citations
Peers
Comparison fields: 5 of 79
- Cardiology and Cardiovascular Medicine 192
- Immunology 108
- Surgery 125
- Molecular Biology 146
- Biotechnology 18
Countries citing papers authored by Meilin Liu
This map shows the geographic impact of Meilin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilin Liu more than expected).
Fields of papers citing papers by Meilin Liu
This network shows the impact of papers produced by Meilin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilin Liu. The network helps show where Meilin Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meilin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 17 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 24 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 0 | |
| 13 | 2021 | 18 | |
| 14 | 2020 | 0 | |
| 15 | 2018 | 9 | |
| 16 | 2017 | 28 | |
| 17 | 2012 | 0 | |
| 18 | 2012 | 14 | |
| 19 | The therapeutic efficacy and safety of different statins in elderly | 2010 | 1 |
| 20 | 1999 | 37 |
About Meilin Liu
Meilin Liu is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Immunology, having authored 45 papers that have together received 478 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cancer, Lipids, and Metabolism (5 papers), Blood Pressure and Hypertension Studies (3 papers), Lipid metabolism and disorders (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Cardiac Fibrosis and Remodeling (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (192 citations), Immunology (108 citations) and Surgery (125 citations). Meilin Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiang Cheng, Ni Xia, Zhengfeng Zhu, Xiaochuan Xie, Tingting Tang, Shaofang Nie, Muyang Gu, Bingjie Lv, Xiang‐Ping Yang and Yuhua Liao. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.